Core Viewpoint - The article discusses a significant study identifying rare genetic variants associated with Attention Deficit Hyperactivity Disorder (ADHD), revealing that individuals carrying these variants have a substantially higher risk of developing ADHD compared to the general population [4][9]. Group 1: ADHD Overview - ADHD is a neurodevelopmental disorder affecting approximately 5% of children globally, with about half of these cases persisting into adulthood, leading to various severe consequences [3]. - The study highlights the importance of understanding the biological mechanisms driving ADHD for future treatment and intervention strategies [3]. Group 2: Research Findings - A groundbreaking study published in Nature identified three rare genetic variants—MAP1A, ANO8, and ANK2—significantly linked to ADHD risk, with individuals carrying these variants having a 5.55 to 15.31 times higher risk of developing the disorder [4][9]. - The research involved a large sample size of 8,895 ADHD patients and 53,780 healthy controls, focusing on rare coding gene variants that can severely impact protein function [7]. Group 3: Genetic Mechanisms - MAP1A is crucial for microtubule assembly and neuronal structure, while ANO8 and ANK2 are involved in calcium ion transport, indicating that ion channel dysfunction plays a significant role in ADHD [11]. - The study found that these rare variants not only increase the risk of ADHD but also significantly affect cognitive function and socioeconomic status, with carriers being 24% more likely to complete only basic education and 28% more likely to experience low socioeconomic status [14]. Group 4: Combined Genetic Effects - The research explored the combined effects of common and rare genetic variants, revealing that they contribute to ADHD risk additively, with rare variants acting as risk accelerators [17]. Group 5: Implications for Future Research - The findings suggest that the identified genes explain only 5.2% of the heritability associated with rare variants, indicating that more ADHD risk genes remain to be discovered [19]. - Long-term implications include the potential for developing precise diagnostic methods, personalized treatment strategies, and reducing stigma associated with ADHD by clarifying its biological basis [20].

Core Insights - The article discusses a significant research study on the nucleus basalis of Meynert (nbM), highlighting its role in regulating cortical functions, learning, and memory, and its association with neurodegenerative diseases and developmental disorders [2][3]. Group 1: Research Findings - The research team successfully generated human nucleus basalis organoids (hnbMO) from human pluripotent stem cells (hPSC), which contain functional cholinergic projection neurons [5]. - The study established long-distance cholinergic projection pathways from nbM to the cerebral cortex by co-culturing hnbMO with fetal brain tissue and transplanting it into immunodeficient mice [5]. - The nbM-cortical organoid assembloids demonstrated human-specific cholinergic projection systems, confirming the functional connectivity between hnbMO and human cortical organoids (hCO) [5][6]. Group 2: Application and Implications - The organoid assembloids revealed projection defects in organoids derived from patients with Down syndrome, indicating their potential application in studying nbM-related neural circuits and neurological disorders [6]. - The research underscores the importance of the nbM-cortical cholinergic pathway in understanding the mechanisms underlying various neurological conditions [3][6].

Core Insights - The research presents the first detailed cross-species mammalian brain cell development atlas, providing unprecedented reference for understanding early brain formation and the origins of neurodevelopmental disorders [1][2][3] - Approximately 15% of children and adolescents are affected by neurodevelopmental disorders, highlighting the urgency of understanding critical periods of brain development [1] Group 1: Research Findings - The study, part of the BRAIN Initiative Cell Atlas Network (BICAN), integrates single-cell genomics, spatial transcriptomics, and advanced imaging techniques to construct a comprehensive brain cell atlas across multiple species [1] - A focus on GABAergic inhibitory neurons in the mouse forebrain revealed their migration process from birthplace to functional locations, which is crucial for motor, memory, and emotional regulation [2] - The research tracked over 770,000 single cells in the mouse visual cortex from embryonic to early adult stages, showing that brain cell diversification continues after birth, particularly during the initial visual experiences [2] Group 2: Implications for Future Research - The use of BARseq technology allowed for the mapping of gene expression profiles of millions of neurons, confirming the critical role of sensory experiences in brain region specialization [3] - The findings provide a solid framework for studying the origins of developmental disorders such as autism and schizophrenia, potentially leading to early diagnosis and targeted interventions [3]

Core Viewpoint - The study reveals that maternal immune activation due to viral infection leads to abnormal secretion of extracellular granzyme B (GzmB) by natural killer (NK) cells, which crosses the maternal-fetal barrier, resulting in the accumulation of fetal macrophages and activation of microglia, ultimately causing neurodevelopmental disorders and behavioral defects in offspring [2][3][6]. Group 1: Research Findings - Maternal NK cells activated by viral infection promote the accumulation of activated macrophages in the fetal brain, leading to neurodevelopmental disorders and behavioral defects in offspring [3][6]. - Extracellular granzyme B (GzmB) is released by maternal CD49a+ tissue-resident NK cell subsets under type I interferon stimulation, crossing the maternal-fetal barrier and promoting the accumulation of fetal macrophages expressing interferon-stimulated genes (ISG) and activation of microglia [3][6]. - Targeting extracellular GzmB by systemic administration of serine protease inhibitor Serpina3n or knocking out the GzmB gene in maternal NK cells can alleviate neuroimmune disorders in the fetal brain induced by maternal immune activation [3][6]. Group 2: Implications - The findings indicate that exposure to a disrupted maternal environment reprograms the immune function of decidual NK cells, disrupting the neuroimmune balance in the fetus and increasing the risk of neurodevelopmental disorders in offspring [6].